Michael R. McMullen - Jul 29, 2024 Form 4 Insider Report for BRISTOL MYERS SQUIBB CO (BMY)

Role
Director
Signature
/s/ Lisa A. Atkins, attorney-in-fact for Michael R. McMullen
Stock symbol
BMY
Transactions as of
Jul 29, 2024
Transactions value $
$0
Form type
4
Date filed
7/31/2024, 08:12 PM
Previous filing
Jul 2, 2024
Next filing
Oct 2, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BMY Call Option (obligation to sell) Other $0 -5 -100% $0.00* 0 Jul 29, 2024 Common Stock, $0.10 par value 500 $46.00 Family Trust F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Prior to the reporting person joining the Board of Directors of Bristol-Myers Squibb Company, the family trust of the reporting person wrote five covered call options with respect to a total of 500 shares of common stock beneficially owned by the reporting person and held in a managed account. On July 29, 2024, the family trust of the reporting person cancelled these call options by purchasing five identical call options at a price of $3.85 per underlying share, thus closing the option position.
F2 Securities held in a family trust, where reporting person is the trustee and a beneficiary.